Literature DB >> 22456588

Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection: a pilot study in Zambia, Africa.

Knut A Hestad1, J Anitha Menon, Mary Silalukey-Ngoma, Donald R Franklin, Mwiya L Imasiku, Kalima Kalima, Robert K Heaton.   

Abstract

This study examined whether there are neuropsychological performance differences between human immunodeficiency virus-seropositive participants being followed at a University of Zambia clinic and demographically comparable seronegative controls being tested for infection in the same setting. All participants were administered a standardized neurocognitive test battery that has been found sensitive to HIV-associated Neurocognitive Disorder in the United States and internationally (e.g., in China, India, Romania, and Cameroon). The test battery was found to be applicable to a Zambian population. A clear HIV effect was seen with a medium to large overall effect size (Cohen d = 0.74). However, it was only the female seropositive participants who showed this HIV effect. HIV can result in neuropsychological deficits in Zambia, where clade C of the virus dominates. It is suggested that the HIV-infected women are more at risk of developing cognitive deficits than are men in this population, possibly because of sex-related social, financial, and healthcare disadvantages. However, further analyses are required regarding this conclusion because the finding was a result of an unplanned subanalysis.

Entities:  

Mesh:

Year:  2012        PMID: 22456588      PMCID: PMC3886829          DOI: 10.1097/NMD.0b013e31824cc225

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  29 in total

1.  Evaluation of two new neuropsychological tests designed to minimize cultural bias in the assessment of HIV-1 seropositive persons: a WHO study.

Authors:  M Maj; L D'Elia; P Satz; R Janssen; M Zaudig; C Uchiyama; F Starace; S Galderisi; A Chervinsky
Journal:  Arch Clin Neuropsychol       Date:  1993-03       Impact factor: 2.813

Review 2.  Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force.

Authors: 
Journal:  Neurology       Date:  1991-06       Impact factor: 9.910

3.  Variable progression of HIV-associated dementia.

Authors:  F H Bouwman; R L Skolasky; D Hes; O A Selnes; J D Glass; T E Nance-Sproson; W Royal; G J Dal Pan; J C McArthur
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

4.  HTLV-III infection in brains of children and adults with AIDS encephalopathy.

Authors:  G M Shaw; M E Harper; B H Hahn; L G Epstein; D C Gajdusek; R W Price; B A Navia; C K Petito; C J O'Hara; J E Groopman
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

5.  Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus.

Authors:  Tokugha Yepthomi; Robert Paul; Snigdha Vallabhaneni; N Kumarasamy; David F Tate; Suniti Solomon; Timothy Flanigan
Journal:  J Int Neuropsychol Soc       Date:  2006-05       Impact factor: 2.892

6.  Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa.

Authors:  N Sacktor; N Nakasujja; R Skolasky; K Robertson; M Wong; S Musisi; A Ronald; E Katabira
Journal:  Neurology       Date:  2006-07-25       Impact factor: 9.910

7.  Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia.

Authors:  David B Clifford; Mesfin T Mitike; Yared Mekonnen; Jiameng Zhang; Guta Zenebe; Zenebe Melaku; Ayele Zewde; Neway Gessesse; Dawit Wolday; Tsehaynesh Messele; Mengesha Teshome; Scott Evans
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

8.  Women and HIV infection: a cohort study of 483 HIV-infected women in Bordeaux, France, 1985-1991. The Groupe d'Epidémiologie Clinique du SIDA en Aquitaine.

Authors:  P Morlat; P Parneix; D Douard; D Lacoste; M Dupon; G Chêne; J L Pellegrin; J M Ragnaud; F Dabis
Journal:  AIDS       Date:  1992-10       Impact factor: 4.177

9.  Closing gaps in antiretroviral therapy access: human immunodeficiency virus-associated dementia screening instruments for non-physician healthcare workers.

Authors:  Michelle P Kvalsund; Alan Haworth; Daniel L Murman; Ellen Velie; Gretchen L Birbeck
Journal:  Am J Trop Med Hyg       Date:  2009-06       Impact factor: 2.345

10.  Pattern of neuropsychological performance among HIV positive patients in Uganda.

Authors:  Kevin R Robertson; Noeline Nakasujja; Matthew Wong; Seggane Musisi; Elly Katabira; Thomas D Parsons; Allan Ronald; Ned Sacktor
Journal:  BMC Neurol       Date:  2007-04-05       Impact factor: 2.474

View more
  42 in total

1.  Sex differences in HIV-associated cognitive impairment.

Authors:  Erin E Sundermann; Robert K Heaton; Elizabeth Pasipanodya; Raeanne C Moore; Emily W Paolillo; Leah H Rubin; Ronald Ellis; David J Moore
Journal:  AIDS       Date:  2018-11-28       Impact factor: 4.177

2.  Cognitive Impairment in Zambians With HIV Infection and Pulmonary Tuberculosis.

Authors:  Knut A Hestad; Jonathan Chinyama; Menon J Anitha; Mary S Ngoma; J Allen McCutchan; Donald R Franklin; Robert K Heaton
Journal:  J Acquir Immune Defic Syndr       Date:  2019-01-01       Impact factor: 3.731

3.  Selective monoaminergic and histaminergic circuit dysregulation following long-term HIV-1 protein exposure.

Authors:  Adam R Denton; Srimal A Samaranayake; Kristin N Kirchner; Robert F Roscoe; Shane N Berger; Steven B Harrod; Charles F Mactutus; Parastoo Hashemi; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2019-05-17       Impact factor: 2.643

4.  Use of Western Neuropsychological Test Battery in Detecting HIV-Associated Neurocognitive Disorders (HAND) in Zambia.

Authors:  Norma Kabuba; J Anitha Menon; Donald R Franklin; Robert K Heaton; Knut A Hestad
Journal:  AIDS Behav       Date:  2017-06

5.  Impact of aging on neurocognitive performance in previously antiretroviral-naive HIV-infected individuals on their first suppressive regimen.

Authors:  Hamza Coban; Kevin Robertson; Marlene Smurzynski; Supriya Krishnan; Kunling Wu; Ronald J Bosch; Ann C Collier; Ronald J Ellis
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.177

6.  Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment.

Authors:  Saurabh Gupta; Jennifer E Iudicello; Chuan Shi; Scott Letendre; Adam Knight; Jianhua Li; Patricia K Riggs; Donald R Franklin; Nichole Duarte; Hua Jin; J Hampton Atkinson; Xin Yu; Zunyou Wu; Igor Grant; Robert K Heaton
Journal:  Drug Alcohol Depend       Date:  2014-01-13       Impact factor: 4.492

Review 7.  Epidemiology of neurodegenerative diseases in sub-Saharan Africa: a systematic review.

Authors:  Alain Lekoubou; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  BMC Public Health       Date:  2014-06-26       Impact factor: 3.295

8.  Cognitive impairment and psychiatric morbidity in HIV+ Zambians with new-onset seizure.

Authors:  Lisa Kalungwana; Melissa A Elafros; Omar K Siddiqi; Christopher M Bositis; Izukanji Sikazwe; Igor J Koralnik; William H Theodore; Gretchen L Birbeck
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

9.  Chronic HIV-1 Tat and HIV reduce Rbfox3/NeuN: evidence for sex-related effects.

Authors:  Yun Kyung Hahn; Ruturaj R Masvekar; Ruqiang Xu; Kurt F Hauser; Pamela E Knapp
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

10.  Longitudinal neuropsychological test performance among HIV seropositive individuals in Uganda.

Authors:  Ned Sacktor; Noeline Nakasujja; Ozioma Okonkwo; Richard L Skolasky; Kevin Robertson; Seggane Musisi; Elly Katabira
Journal:  J Neurovirol       Date:  2013-01-12       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.